SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets close in 27 mins.

Sanofi (SNY)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
44.51-0.16 (-0.37%)
As of 3:33PM EDT. Market open.
People also watch
NVSGSKAZNLLYNVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close44.67
Open44.69
Bid0.00 x
Ask0.00 x
Day's Range44.49 - 45.13
52 Week Range36.81 - 45.13
Volume1,042,846
Avg. Volume1,699,471
Market Cap109.99B
Beta0.76
PE Ratio (TTM)23.01
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.58 (3.56%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can
    Investor's Business Daily1 hour ago

    Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can

    Regeneron expects to top Amgen's recent heart-drug study in a team-up with Sanofi.

  • American City Business Journals2 hours ago

    Flexion tops $800M in market cap on Sanofi buyout rumor

    Shares of Burlington biotech Flexion Therapeutics soared to their highest point in more than a year and a half on Thursday following an unconfirmed report that French drug giant Sanofi is in talks to acquire the company for more than $1 billion. FiercePharma, citing an unnamed source, reported Thursday morning that the board of Flexion (FLXN) has voted to accept a non-binding offer from Sanofi (SNY), the parent company of Cambridge-based Sanofi-Genzyme. A Flexion spokesman declined comment, adding that the biotech will continue to pursue an “independent” strategy with its lead product, Zilretta, a long-acting steroid injection for osteoarthritis of the knee that could compete with one of Sanofi’s own treatments, Synvisc.

  • TheStreet.com4 hours ago

    Sanofi Said to Be Near $1 Billion Deal for Flexion

    Flexion is an arthritis-focused biotech company.